EUVIMEDEUVIMED entdecken
Crossref

Exploring Aza-BODIPY Derivatives as Sonosensitizers for Deep-Tissue Sonotheranostics in Breast Cancer

Xiaofeng He iD, Menglong Zhao, Jiatian Song, Junwei Li, Jiahui Wang, Peixiu Yao, Jiayu Li, Zhiyong Wu, Yunjian Xu iD, Tiantian Zhai, Siqi Qiu iD

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c14426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Xiaofeng He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Cancer Hospital of Shantou University Medical College, Shantou515000, China. Hauptthemen laut MEDLINE: Boron Compounds, Breast Neoplasms, Ultrasonic Therapy, Antineoplastic Agents. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Medical Research Foundation, Ministry of Finance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sonodynamic therapy (SDT) is an emerging noninvasive treatment for tumors with the advantage of deep tissue penetration. However, it is still challenging to develop effective organic sonosensitizers with good stability for imaging and SDT. In this work, in order to reveal the structure–activity relationship of sonosensitizers, we designed and synthesized a series of aza-BODIPY derivatives (AB1–AB5) with different substituents (methoxy, octyloxy, anthracene, and iodine atom) to systematically evaluate the influence of electron-donating effect and heavy atom effect on the sonodynamic efficacy. Among them, the iodine-substituted aza-BODIPY (AB5) demonstrated superior sonodynamic performance and exhibited enhanced reactive oxygen species (ROS) generation. Subsequently, we encapsulated AB5 with the hydrophilic polymer DSPE-mPEG2000 to create nanoparticles referred to as iodinated aza-BODIPY nanoparticles (IABNPs). In vitro cellular assays and in vivo animal experiments showed that IABNPs had excellent stability, biocompatibility, and pronounced sonodynamic effect, which resulted in significant inhibition of tumor growth. Moreover, the fluorescent emission characteristics of AB5 enabled fluorescence-guided imaging and real-time monitoring during tumor treatment. This study systematically explored the influence of substituents on the sonodynamic effect of aza-BODIPY, providing important theoretical foundations and perspectives for future research in related fields.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron CompoundsBreast NeoplasmsUltrasonic TherapyAntineoplastic AgentsAnimalsFemaleHumansNanoparticlesMiceReactive Oxygen SpeciesCell Line, TumorTheranostic Nanomedicine

Stichwörter der Autor:innen

aza-BODIPYbreast cancerfluorescence imagingheavy-atom effectsonodynamic therapy

Substanzen

Boron CompoundsazaBDPBA compoundReactive Oxygen Species4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Radiotherapy, Cancer Hospital of Shantou University Medical College, Shantou515000, China.
  • Department of Clinical Research Center and Shantou Key Laboratory of Basic and Translational Research of Malignant Tumors, Shantou Clinical Medical College of Jinan University (Shantou Central Hospital), Jinan Universit…
  • Shantou University Medical College , Shantou515041, China.
  • Department of Biobank, Shantou Central Hospital, Shantou515031, China.
  • Department of Diagnosis and Treatment Center of Breast Diseases, Shantou Clinical Medical College of Jinan University (Shantou Central Hospital), Jinan University, Shantou515031, China.
  • School of Radiology, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian271016, China.

ORCID-Profile: Xiaofeng He, Yunjian Xu, Siqi Qiu

Förderung

  • National Natural Science Foundation of China
  • Guangdong Medical Research Foundation
  • Ministry of Finance
  • Natural Science Foundation of Shandong Province
  • Traditional Chinese Medicine Bureau of Guangdong Province
  • Science and Technology Planning Project of Guangdong Province
  • Guangdong Special Support Plan
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

He, X., Zhao, M., Song, J., Li, J., Wang, J., Yao, P., Li, J., Wu, Z., Xu, Y., Zhai, T., & Qiu, S. (2026). Exploring Aza-BODIPY Derivatives as Sonosensitizers for Deep-Tissue Sonotheranostics in Breast Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c14426

Vancouver

He X, Zhao M, Song J, Li J, Wang J, Yao P, et al. Exploring Aza-BODIPY Derivatives as Sonosensitizers for Deep-Tissue Sonotheranostics in Breast Cancer. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c14426

BibTeX
@article{He2026,
  author = {He, Xiaofeng and Zhao, Menglong and Song, Jiatian and Li, Junwei and Wang, Jiahui and Yao, Peixiu and Li, Jiayu and Wu, Zhiyong and Xu, Yunjian and Zhai, Tiantian and Qiu, Siqi},
  title = {Exploring Aza-BODIPY Derivatives as Sonosensitizers for Deep-Tissue Sonotheranostics in Breast Cancer},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c14426}
}
Kostenlos starten →